For example, in MS, CSF and blood levels of neurodegeneration‐associated biomarkers—such as neurofilament light chain (NFL) and heavy chain (NFH—have been validated as strong predictors of disease severity [780, 781]. The gene discussed is NEFL; the disease is myeloid sarcoma.